Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biochemistry

• Publication date

  2011-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/bi1020138PMID 21235237PMCID PMC3040069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold

  2011cited by this paper
• Pak protein kinases and their role in cancer

  2009cited by this paper
• The effector repertoire of enteropathogenic E. coli: ganging up on the host cell

  2009cited by this paper
• Molecular Pathogenesis of Shigella spp.: Controlling Host Cell Signaling, Invasion, and Death by Type III Secretion

  2008cited by this paper
• On the Rho'd: The regulation of membrane protrusions by Rho‐GTPases

  2008cited by this paper
• Novel fold of VirA, a type III secretion system effector protein from Shigella flexneri

  2008cited by this paper
• Structural and functional studies indicate that Shigella VirA is not a protease and does not directly destabilize microtubules.

  2008cited by this paper
• Subversion of actin dynamics by EPEC and EHEC.

  2006cited by this paper
• Microtubule-Severing Activity of Shigella Is Pivotal for Intercellular Spreading

  2006cited by this paper
• Function and distribution of EspG2, a type III secretion system effector of enteropathogenic Escherichia coli.

  2006cited by this paper
• Modulation of Host Cytoskeleton Function by the Enteropathogenic Escherichia coli and Citrobacter rodentium Effector Protein EspG

  2005cited by this paper
• Enteropathogenic Escherichia coli Type III Effectors EspG and EspG2 Disrupt the Microtubule Network of Intestinal Epithelial Cells

  2005cited by this paper
• Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF‐H1

  2004cited by this paper
• Regulation of protein kinases; controlling activity through activation segment conformation.

  2004cited by this paper
• Process of Protein Transport by the Type III Secretion System

  2004cited by this paper
• Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization

  2002cited by this paper
• Assay of Cdc42, Rac, and Rho GTPase activation by affinity methods.

  2002cited by this paper
• EspG, a Novel Type III System-Secreted Protein from Enteropathogenic Escherichia coli with Similarities to VirA of Shigella flexneri

  2001cited by this paper
• Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch.

  2000cited by this paper
• Single-wavelength anomalous diffraction phasing revisited.

  2000cited by this paper
• Regulation of the small GTP‐binding protein Rho by cell adhesion and the cytoskeleton

  1999influential reference
• Agents That Inhibit Rho, Rac, and Cdc42 Do Not Block Formation of Actin Pedestals in HeLa Cells Infected with Enteropathogenic Escherichia coli

  1998cited by this paper
• Diarrheagenic Escherichia coli

  1998cited by this paper
• reveals effects of the kinase on actin and focal Expression of constitutively active alpha-PAK

  1997cited by this paper
• Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells.

  1997cited by this paper
• Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes

  1997cited by this paper
• Interactions between enteropathogenic Escherichia coli and host epithelial cells.

  1997cited by this paper
• Identification of a novel virulence gene, virA, on the large plasmid of Shigella, involved in invasion and intercellular spreading

  1995cited by this paper

• α-Helices in the Type III Secretion Effectors: A Prevalent Feature with Versatile Roles

  2021cites this paper
• Mode of action of a novel lymphocyte inhibitory factor of attaching and effacing Escherichia coli

  2020cites this paper
• Molecular Mechanisms That Define Redox Balance Function in Pathogen-Host Interactions—Is There a Role for Dietary Bioactive Polyphenols?

  2019cites this paper
• Pathogenic Escherichia coli Hijacks GTPase-Activated p21-Activated Kinase for Actin Pedestal Formation

  2019cites this paper
• Design of small molecule inhibitors of type III secretion system ATPase EscN from enteropathogenic Escherichia coli.

  2017cites this paper
• Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens

  2017cites this paper
• Modulation of epithelial cell polarity by bacterial pathogens

  2017cites this paper
• Inhibition of WAVE Regulatory Complex Activation by a Bacterial Virulence Effector Counteracts Pathogen Phagocytosis

  2016influential citation
• Enterohaemorrhagic E. coli modulates an ARF6:Rab35 signaling axis to prevent recycling endosome maturation during infection

  2016cites this paper
• Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli

  2016cites this paper
• Enteropathogenic breaking the intestinal tight junction E . coli : barrier

  2016cites this paper
• Enteropathogenic E. coli: breaking the intestinal tight junction barrier

  2015cites this paper
• Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli

  2014cites this paper
• Enterohaemorrhagic Escherichia coli inhibits recycling endosome function and trafficking of surface receptors

  2014cites this paper
• The Locus of Enterocyte Effacement and Associated Virulence Factors of Enterohemorrhagic Escherichia coli

  2014cites this paper
• Republished: Tracing PAKs from GI inflammation to cancer

  2014cites this paper
• Mechanisms of epithelial morphogenesis and integrity during Nematostella vectensis development and Shigella pathogenesis

  2014cites this paper
• Tracing PAKs from GI inflammation to cancer

  2014cites this paper
• Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration

  2014influential citation
• Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors.

  2013cites this paper
• Subversion of the Host Cell by Enteropathogenic Escherichia coli through Effector Interplay

  2012cites this paper
• Actin Cytoskeleton Manipulation by Effector Proteins Secreted by Diarrheagenic Escherichia coli Pathotypes

  2012cites this paper
• Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses.

  2012influential citation
• Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms

  2012cites this paper
• Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements

  2011cites this paper
• Manipulation of kinase signaling by bacterial pathogens

  2011cites this paper
• Biochemistry and cell signaling taught by bacterial effectors.

  2011cites this paper
• Bacterial Scaffolds Assemble Novel Higher-Order Complexes to Reengineer Eukaryotic Cell Processes

  2011cites this paper
• EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function

  2011cites this paper
• Elucidating the function of the type-III secreted effector proteins EspZ and NleC of the attaching and effacing bacterial pathogens

  2011cites this paper